FDAHealthOctober 10, 2025
Endo USA, Inc. — Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119
⚠️ Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- October 10, 2025
Nationwide within the United States
What's affected?
- Product
- Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
- Brand
- EVEROLIMUS
- Lot code
- 550172201
Additional details
Lot #: 550172201, Exp. Date JAN-26; 550184801, Exp. Date MAR-26; 550204001, Exp. Date JUL-26
What should I do?
Recommended action
Class III recall. Voluntary: Firm initiated Quantity affected: 2,035 cartons.
Get Health recall alerts
Delivered to your inbox. Free. No account required.